Potassium Ion

Potassium Ion

SCHEMBL1124622

O=C([O-])OC(=O)[O-].[K+].[K+]

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

AGTR1DHFRGABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTNR3C2PBP2XPTGS1PTGS2VKORC1blablaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAftsImrcAmrcBmrdApbp1apbp1bpbp2apbp2bpbp3polthyA

The experimentally established mechanism targets of Potassium Ion. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Potassium Ion SCHEMBL2987019 0.92 CA4 (0.40)
Ethylene SCHEMBL31460785 0.92 CA4 (0.40)
SCHEMBL1706124 0.91
Zinc Ion SCHEMBL6294528 0.91
SCHEMBL2214402 0.91
SCHEMBL10459297 0.91
SCHEMBL6294539 0.91 CA4 (0.36)
SCHEMBL526233 0.91
SCHEMBL6541926 0.91 CA4 (0.36)
SCHEMBL4359131 0.91 CA4 (0.36)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 102 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025106826-A1 METHOD FOR MANUFACTURING ORGANIC LIQUID FERTILIZER DIGESTED ORGANICS LLC (US) 2025-05-22 WO claimed
US-9764317-B2 Catalysts for preparation of butadiene by oxydehydrogenation of butene in fluidized bed reactor and method of preparing same and use of same SHANGHAI BI KE CLEAN ENERGY TECHNOLOGY CO., LTD. (CN) 2017-09-19 US claimed
US-20150165432-A1 CATALYSTS FOR PREPARATION OF BUTADIENE BY OXYDEHYDROGENATION OF BUTENE IN FLUIDIZED BED REACTOR AND METHOD OF PREPARING SAME AND USE OF SAME SHANGHAI BI KE CLEAN ENERGY TECHNOLOGY CO., LTD. (CN) 2015-06-18 US claimed
EP-2873458-A1 BUTADIENE CATALYST FOR FLUIDIZED BED REACTOR PREPARED BY OXIDIZING AND DEHYDROGENATING BUTYLENE, AND PREPARATION METHOD AND USE THEREOF Shanghai Bi Ke Clean Energy Technology Co. Ltd (CN) 2015-05-20 EP claimed
EP-2283823-A1 Effervescent formulations comprising a phosphonate and methods for their preparation Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A. (GR) 2011-02-16 EP claimed
US-20250215349-A1 USE OF A LUBRICANT COMPOSITION FOR LUBRICATING WORK TOOL KLUEBER LUBRICATION MUENCHEN GMBH & CO. KG (DE) 2025-07-03 US disclosed
WO-2025106826-A1 METHOD FOR MANUFACTURING ORGANIC LIQUID FERTILIZER DIGESTED ORGANICS LLC (US) 2025-05-22 WO disclosed
EP-4499789-A1 USE OF A LUBRICANT COMPOSITION FOR LUBRICATING EQUIPMENT Klueber Lubrication München GmbH & Co. KG (DE) 2025-02-05 EP disclosed
US-12077510-B2 Carboxylic acid compounds Sumitomo Pharma Co., Ltd. (JP) 2024-09-03 US disclosed
US-20240228504-A1 SUBSTITUTED TRICYCLIC AMIDES, ANALOGUES THEREOF, AND METHODS USING SAME ARBUTUS BIOPHARMA CORPORATION (CA) 2024-07-11 US disclosed
US-20240166612-A1 ARYLTHIOETHER ACETAMIDE AND RELATED COMPOUNDS AND THEIR USE IN TREATING MEDICAL CONDITIONS X-BIOTIX THERAPEUTICS, INC. 2024-05-23 US disclosed
CN-110799190-B Heterocyclic compounds 卡都瑞恩医药有限公司 2024-04-19 CN disclosed
WO-2000069833-A1 SUBSTITUTED POLYCYCLIC ARYL AND HETEROARYL URACILS AS ANTICOAGULATIVE AGENTS PHARMACIA CORPORATION (US) 2000-11-23 WO disclosed
US-6015569-A PYRIDINE OR PYRROLE DERIVATIVES OF POLYCYCLIC AROMATICS CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA (FR) 2000-01-18 US disclosed
WO-1999038862-A1 FARNESYL TRANSFERASE INHIBITORS HAVING A PIPERIDINE STRUCTURE AND PROCESS FOR PREPARATION THEREOF LG CHEMICAL LTD. (KR) 1999-08-05 WO disclosed
US-5766610-A USEFUL FOR TREATMENT OF MAMMALIAN SKIN AND HAIR, RHEUMATISM, RESIPIRATORY SYSTEM DISORDER, CARDIOVASCULAR AND VISION DISORDERS CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA (FR) 1998-06-16 US disclosed
WO-1996028023-A2 SYNERGISTS OF BACILLUS THURINGIENSIS DELTA-ENDOTOXIN ABBOTT LABORATORIES (US) 1996-09-19 WO disclosed
US-4609654-A BACTERICIDES SANOFI (FR) 1986-09-02 US disclosed
US-4277632-A CATALYTIC HYDROLYSIS OF CORRESPONDING ALKYLENE OXIDE WITH MOLYBDENUM OR TUNGSTEN CATALYST NIPPON SHOKUBAI KAGUKU KOGYO CO., LTD. (JP) 1981-07-07 US disclosed
US-4172726-A TRIVALENT COBALT COMPLEX AND ORGANIC PHOSPHONIC ACID COMPOUND FUJI PHOTO FILM CO., LTD. (JP) 1979-10-30 US disclosed